|
English
|
正體中文
|
简体中文
|
2826201
|
|
???header.visitor??? :
31838235
???header.onlineuser??? :
3655
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"bronowicki j p"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-09-04T06:11:39Z |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study
|
Manns M.; Pol S.; Jacobson I.M.; Marcellin P.; Gordon S.C.; Peng C.-Y.; Chang T.-T.; Everson G.T.; Heo J.; Gerken G.; Yoffe B.; Towner W.J.; Bourliere M.; Metivier S.; Chu C.-J.; Sievert W.; Bronowicki J.-P.; Thabut D.; Lee Y.-J.; JIA-HORNG KAO; McPhee F.; Kopit J.; Mendez P.; Linaberry M.; Hughes E.; Noviello S. |
| 臺大學術典藏 |
2021-08-31T06:29:40Z |
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Bruix J.; Qin S.; Merle P.; Granito A.; Huang Y.-H.; Bodoky G.; Pracht M.; Yokosuka O.; Rosmorduc O.; Breder V.; Gerolami R.; Masi G.; Ross P.J.; Song T.; Bronowicki J.-P.; Ollivier-Hourmand I.; Kudo M.; ANN-LII CHENG; Llovet J.M.; Finn R.S.; LeBerre M.-A.; Baumhauer A.; Meinhardt G.; Han G. |
| 臺大學術典藏 |
2018-09-10T14:59:23Z |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study
|
Manns, M.;Pol, S.;Jacobson, I.M.;Marcellin, P.;Gordon, S.C.;Peng, C.-Y.;Chang, T.-T.;Everson, G.T.;Heo, J.;Gerken, G.;Yoffe, B.;Towner, W.J.;Bourliere, M.;Metivier, S.;Chu, C.-J.;Sievert, W.;Bronowicki, J.-P.;Thabut, D.;Lee, Y.-J.;Kao, J.-H.;Mcphee, F.;Kopit, J.;Mendez, P.;Linaberry, M.;Hughes, E.;Noviello, S.; JIA-HORNG KAO |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
